Accretive Health, Inc. (AH) is a hated stock today, as just about everything that could go wrong for this high-flyer has gone wrong, and investors still await the outcome of the incorrect booking of its revenues for at least the last nine quarters, saying it will have to restate all its quarterly financial statements back to the second quarter of 2010. It has also warned investors they can't rely on any of the financial statements it released for the 2009, 2010 and 2011 fiscal years.
Accretive said in March it was "still assessing whether restatement will be required for prior periods." So far there has been no communication or indication of how the errors were committed.
Only subscribers can access this article, which is part of the PRO research library covering 3,617 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: